[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @zipjet zipjet zipjet posts on X about $ocul, $tgtx, accounting, future the most. They currently have XXXXX followers and 2444 posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::23257566/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +85% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XX% ### Mentions: X [#](/creator/twitter::23257566/posts_active)  - X Week XX -XX% - X Month XXX -XXXX% - X Months XXX +67% - X Year XXXXX -XXXX% ### Followers: XXXXX [#](/creator/twitter::23257566/followers)  - X Week XXXXX -XXXX% - X Month XXXXX +1.10% - X Months XXXXX +14% - X Year XXXXX +26% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::23257566/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [technology brands](/list/technology-brands) [cryptocurrencies](/list/cryptocurrencies) **Social topic influence** [$ocul](/topic/$ocul) #8, [$tgtx](/topic/$tgtx), [accounting](/topic/accounting), [future](/topic/future), [$lqda](/topic/$lqda), [$uthr](/topic/$uthr), [$shak](/topic/$shak) **Top accounts mentioned or mentioned by** [@lucy3370](/creator/undefined) [@semodough](/creator/undefined) [@sandeman52](/creator/undefined) [@elonmusk](/creator/undefined) [@vividprowess](/creator/undefined) [@martychargin](/creator/undefined) [@biomaven](/creator/undefined) [@dreesenkl](/creator/undefined) [@biotech2050](/creator/undefined) [@sharkbiotech](/creator/undefined) [@drelidavid](/creator/undefined) [@jimiuorio](/creator/undefined) [@chkrosp](/creator/undefined) [@cryptidpolitics](/creator/undefined) [@davidlimbaugh](/creator/undefined) [@limare64](/creator/undefined) [@clarksterh](/creator/undefined) [@sullycnbc](/creator/undefined) [@guydealership](/creator/undefined) [@ronaldtgoldman](/creator/undefined) **Top assets mentioned** [Ocular Therapeutix, Inc. (OCUL)](/topic/$ocul) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Liquidia Corporation Common Stock (LQDA)](/topic/$lqda) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Shakita Inu (SHAK)](/topic/$shak) ### Top Social Posts Top posts by engagements in the last XX hours "@safwan22025 $TGTX Those earnings are really an accounting artifact. There were no sales to support the vast majority of those EPS no cash flows. Those earnings are essentially a recognition that the prior losses will shelter future earnings" [X Link](https://x.com/zipjet/status/1998036512580260138) 2025-12-08T14:26Z 2922 followers, XXX engagements "I wonder if $OCUL could get Axpaxli approved off SOL-1 when it demonstrates SUPERIORITY to Eylea the SOC. IF ONE study is ever going to be sufficient a study conducted under an SPA that demonstrates superiority to SOC AND treats the desperate need to prevent blindness should be one" [X Link](https://x.com/zipjet/status/1996756117423055097) 2025-12-05T01:38Z 2923 followers, 3626 engagements "@diyinvestguy Not a hedge. But a reasonable pair trade is long $LQDA and short $UTHR. I think finding the XXX patent invalid would see UTHR drop 50-100 points" [X Link](https://x.com/zipjet/status/1997837847848726732) 2025-12-08T01:17Z 2921 followers, 1202 engagements "$OCUL 📰 Summary: Ocular Therapeutix Accelerates Plans for Wet AMD Drug AXPAXLI Ocular Therapeutix Inc. has announced it now intends to submit a New Drug Application (NDA) for AXPAXLI (OTX-TKI) for the treatment of wet age-related macular degeneration (wet AMD) following positive year-one data from its ongoing SOL-1 Phase X clinical trial. Key Points: Accelerated Submission: The decision to potentially submit the NDA after only the first year of data is based on recent public statements from FDA leadership regarding the potential for a single registrational trial for new product candidates as" [X Link](https://x.com/zipjet/status/1998007990557835683) 2025-12-08T12:33Z 2922 followers, XXX engagements "@JonahLupton @commonsenseplay $SHAK is worthless IMO. Ate there once. Never again" [X Link](https://x.com/zipjet/status/1997834001332244656) 2025-12-08T01:01Z 2922 followers, XXX engagements "$OCUL We all get some right and some wrong. Some friends told me they wanted to sell OCUL. I told them I thought it would be over XX by the end of this year. They sold at $8.35" [X Link](https://x.com/zipjet/status/1998039262227468379) 2025-12-08T14:37Z 2922 followers, 1445 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@zipjet zipjet
zipjet posts on X about $ocul, $tgtx, accounting, future the most. They currently have XXXXX followers and 2444 posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +85%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XX%
Mentions: X #
- X Week XX -XX%
- X Month XXX -XXXX%
- X Months XXX +67%
- X Year XXXXX -XXXX%
Followers: XXXXX #
- X Week XXXXX -XXXX%
- X Month XXXXX +1.10%
- X Months XXXXX +14%
- X Year XXXXX +26%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks finance technology brands cryptocurrencies
Social topic influence $ocul #8, $tgtx, accounting, future, $lqda, $uthr, $shak
Top accounts mentioned or mentioned by @lucy3370 @semodough @sandeman52 @elonmusk @vividprowess @martychargin @biomaven @dreesenkl @biotech2050 @sharkbiotech @drelidavid @jimiuorio @chkrosp @cryptidpolitics @davidlimbaugh @limare64 @clarksterh @sullycnbc @guydealership @ronaldtgoldman
Top assets mentioned Ocular Therapeutix, Inc. (OCUL) TG Therapeutics, Inc. (TGTX) Liquidia Corporation Common Stock (LQDA) United Therapeutics, Corp. (UTHR) Shakita Inu (SHAK)
Top Social Posts
Top posts by engagements in the last XX hours
"@safwan22025 $TGTX Those earnings are really an accounting artifact. There were no sales to support the vast majority of those EPS no cash flows. Those earnings are essentially a recognition that the prior losses will shelter future earnings"
X Link 2025-12-08T14:26Z 2922 followers, XXX engagements
"I wonder if $OCUL could get Axpaxli approved off SOL-1 when it demonstrates SUPERIORITY to Eylea the SOC. IF ONE study is ever going to be sufficient a study conducted under an SPA that demonstrates superiority to SOC AND treats the desperate need to prevent blindness should be one"
X Link 2025-12-05T01:38Z 2923 followers, 3626 engagements
"@diyinvestguy Not a hedge. But a reasonable pair trade is long $LQDA and short $UTHR. I think finding the XXX patent invalid would see UTHR drop 50-100 points"
X Link 2025-12-08T01:17Z 2921 followers, 1202 engagements
"$OCUL 📰 Summary: Ocular Therapeutix Accelerates Plans for Wet AMD Drug AXPAXLI Ocular Therapeutix Inc. has announced it now intends to submit a New Drug Application (NDA) for AXPAXLI (OTX-TKI) for the treatment of wet age-related macular degeneration (wet AMD) following positive year-one data from its ongoing SOL-1 Phase X clinical trial. Key Points: Accelerated Submission: The decision to potentially submit the NDA after only the first year of data is based on recent public statements from FDA leadership regarding the potential for a single registrational trial for new product candidates as"
X Link 2025-12-08T12:33Z 2922 followers, XXX engagements
"@JonahLupton @commonsenseplay $SHAK is worthless IMO. Ate there once. Never again"
X Link 2025-12-08T01:01Z 2922 followers, XXX engagements
"$OCUL We all get some right and some wrong. Some friends told me they wanted to sell OCUL. I told them I thought it would be over XX by the end of this year. They sold at $8.35"
X Link 2025-12-08T14:37Z 2922 followers, 1445 engagements